These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28165246)

  • 21. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments.
    Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL
    Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound detection of myocardial ischemic memory using an E-selectin targeting peptide amenable to human application.
    Leng X; Wang J; Carson A; Chen X; Fu H; Ottoboni S; Wagner WR; Villanueva FS
    Mol Imaging; 2014; 13():1-9. PubMed ID: 24824960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model.
    Jun HY; Park SH; Kim HS; Yoon KH
    Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
    Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
    PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model.
    Decano JL; Moran AM; Ruiz-Opazo N; Herrera VL
    Mol Imaging Biol; 2011 Dec; 13(6):1096-106. PubMed ID: 20972637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
    Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
    J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121/rGel.
    Cho EJ; Yang J; Mohamedali KA; Lim EK; Kim EJ; Farhangfar CJ; Suh JS; Haam S; Rosenblum MG; Huh YM
    Invest Radiol; 2011 Jul; 46(7):441-9. PubMed ID: 21512397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and measuring combination of KDR-targeted ultrasound contrast agent in vitro for evaluating endometrial receptivity.
    Han X; Chen Y; Yang L; He Y; Chen M; Liu H
    Clin Exp Obstet Gynecol; 2015; 42(5):595-9. PubMed ID: 26524805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin.
    Lindner JR; Song J; Christiansen J; Klibanov AL; Xu F; Ley K
    Circulation; 2001 Oct; 104(17):2107-12. PubMed ID: 11673354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1.
    Weller GE; Lu E; Csikari MM; Klibanov AL; Fischer D; Wagner WR; Villanueva FS
    Circulation; 2003 Jul; 108(2):218-24. PubMed ID: 12835214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
    Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
    Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
    Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
    Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species.
    Bettinger T; Bussat P; Tardy I; Pochon S; Hyvelin JM; Emmel P; Henrioud S; Biolluz N; Willmann JK; Schneider M; Tranquart F
    Invest Radiol; 2012 Sep; 47(9):516-23. PubMed ID: 22814589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can contrast-enhanced US with targeted microbubbles monitor the response to antiangiogenic therapies?
    Kruskal JB
    Radiology; 2008 Feb; 246(2):339-40. PubMed ID: 18227533
    [No Abstract]   [Full Text] [Related]  

  • 37. Rhodamine-loaded intercellular adhesion molecule-1-targeted microbubbles for dual-modality imaging under controlled shear stresses.
    Wu Z; Curaj A; Fokong S; Liehn EA; Weber C; Lammers T; Kiessling F; Zandvoort van M
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):974-81. PubMed ID: 24036383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
    Ellegala DB; Leong-Poi H; Carpenter JE; Klibanov AL; Kaul S; Shaffrey ME; Sklenar J; Lindner JR
    Circulation; 2003 Jul; 108(3):336-41. PubMed ID: 12835208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
    Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
    Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.